Table 4. Features related to FLT3mRNA in 25 AML patients with PML/RARα.
| Feature | No. cases | FLT3mRNA(/GAPDH) | P | |
|---|---|---|---|---|
| Median | Range | |||
| FLT3 mutations | ||||
| + | 16 | 0.303 | 0.018–0.853 | 0.012 |
| − | 9 | 0.103 | 0.005–0.279 | |
| FLT3/ITD | ||||
| + | 9 | 0.402 | 0.068–0.853 | 0.025 |
| − | 16 | 0.135 | 0.005–0.584 | |
| FLT3/D835 | ||||
| + | 9 | 0.203 | 0.018–0.584 | 0.046 |
| − | 16 | 0.247 | 0.005–0.853 | |
| FAB subtype | ||||
| M3 | 20 | 0.184 | 0.005–0.853 | 0.042 |
| M3v | 5 | 0.420 | 0.274–0.782 | |
| PML/RAR isoform | ||||
| Long/bcr1 | 13 | 0.132 | 0.005–0.496 | 0.024 |
| Short/bcr3 | 10 | 0.319 | 0.066–0.782 | |
| Surface markers | ||||
| CD2+ | 10 | 0.369 | 0.068–0.853 | 0.038 |
| CD2− | 15 | 0.140 | 0.005–0.584 | |
| CD34+ | 8 | 0.217 | 0.005–0.438 | 0.540 |
| CD34− | 17 | 0.238 | 0.018–0.853 | |
| CD2+CD34+ | 5 | 0.277 | 0.068–0.438 | 0.637 |
| CD2−CD34− | 12 | 0.145 | 0.018–0.584 | |